Six 20 Minutes Webcasts
ACR POINT-OF-CARE TESTING: A GAME CHANGER FOR DETECTING AND MANAGING KIDNEY DISEASE
エピソードを見る
Prevention and Treatment CKD: Case Study from the Cardiometabolic Institute
Kidney Disease? Case Study from a Diabetes and Lipids Outpatient Clinic
Albumin-to-Creatinine Ratio (ACR) point-of-care testing: successful implementation in the GP office
Impact of ACR POC testing on the diagnosis and management of diabetic kidney disease
Should you screen for kidney damage?
What do the guidelines say?
ACR – The window to early kidney disease
背景
Chronic kidney disease is a common and often silent condition – up to one in ten adults could be affected in Europe, Canada and Israel, yet only one-third of these will have had a diagnosis1. Early detection can slow disease progression or even prevent it altogether2 — which is why testing in at-risk groups is so important.
Join this livestream series of 20 minutes each to learn how early detection can slow disease progression or even prevent it altogether.
Our international speakers will discuss the role of rapid diagnostics in disease prevention, with point-of-care testing such as an Albumin Creatinine Ratio (ACR) assay, enabling healthcare providers to detect, and treat, kidney disease in minutes.
Learn more about current guidelines and kidney disease prevention and management.
Series of six livestream events covering:
- Importance of regular testing for early detection and monitoring in high-risk patients
- Importance of ACR testing beside the determination of eGFR
- Latest guidance on disease prevention and management
- Case studies
-
Sundström J, Bodegard J, Bollmann A et al. CaReMe CKD study: Prevalence, outcomes, and cost of CKD in a contemporary population of 2.4 million patients from 11 countries. The Lancet Regional Health – Europe 2022;00: 100438
-
The International Society of Nephrology (ISN). Chronic Kidney Disease: HYPERLINK https://www.worldkidneyday.org/facts/chronic-kidney-disease
プレゼンテーション
-
PROF. STEPHAN JACOB
(GERMANY)
SpeakerDr. Jacob is an Endocrinologist, Diabetologist, Nutrition Expert and Clinical Hypertension Specialist in Private Practice.
-
DR. HELMUT BRATH
(AUSTRIA)
Speaker -
DR. KRISTIAN JONG HØINES
(NORWAY)
SpeakerSpecialist General Practitioner in Tananger and Assistant Professor at the Department of Global Public Health and Primary Care at the University of Bergen.
-
PROF. GOTTFRIED RUDOFSKY
(SWITZERLAND)
SpeakerSpecialist in Internal Medicine – Endocrinology and Diabetology, Nephrology. Head of private practice in the fields of internal medicine and endocrinology, Olten, Switzerland.
-
PROF. PETER ROSSING
(DENMARK)
SpeakerHead of department for Complications Research at Steno Diabetes Center Copenhagen, and Professor in Endocrinology at Department of Clinical Medicine, University of Copenhagen.
-
PROF. TROND JENSSEN
(NORWAY)
SpeakerProfessor of Nephrology in the Department of Clinical Medicine, University of Oslo, and leader of the Research Group for Transplantation Medicine, Section of Nephrology, Rikshospitalet, Oslo University Hospital.
提示された見解および意見は、著者のみのものです。 このWebキャストに含まれるコンテンツは、情報提供/教育目的のみを目的としています。
© 2022年のアボット。全著作権所有。参照されているすべての商標は、Abbottグループの企業またはそれぞれの所有者の商標です。 COL-16422 01/2023